Cargando…

Transplantation of Autologous Mesenchymal Stem Cells for End-Stage Liver Cirrhosis: A Meta-Analysis Based on Seven Controlled Trials

Background. The bone marrow-derived mesenchymal stem cells (BM-MSCs) have demonstrated great potential as regenerative medicine in different therapeutic applications. This study aims to pool previous controlled clinical trials to make an update assessment of the effectiveness of BM-MSC transplantati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Xiang-Rui, Tang, Ya-Ling, Xuan, Ming, Chang, Zheng, Wang, Xiao-Yi, Liang, Xin-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377544/ https://www.ncbi.nlm.nih.gov/pubmed/25861263 http://dx.doi.org/10.1155/2015/908275

Ejemplares similares

Autologous Stem Cells Transplantation in Egyptian Patients with Liver Cirrhosis on Top of Hepatitis C Virus
por: Al Tayeb, Hoda, et al.
Publicado: (2015)

Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease
por: Salama, Hosny, et al.
Publicado: (2014)

Stem cell transplantation for the treatment of end-stage liver disease
por: Wu, Dong-Bo, et al.
Publicado: (2018)

Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
por: Cao, Yan, et al.
Publicado: (2020)

Surveillance for Hepatocellular Carcinoma after Autologous Stem Cell Transplantation in Cirrhosis
por: Mohamadnejad, Mehdi, et al.
Publicado: (2012)

Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study
por: Wang, Ming-Fang, et al.
Publicado: (2018)

Protective role of melatonin in early‐stage and end‐stage liver cirrhosis
por: Hu, Chenxia, et al.
Publicado: (2019)

Triphase contrast-enhanced CT to evaluate indications for autologous liver transplantation in patients with end-stage hepatic alveolar echinococcosis
por: Chen, Jing, et al.
Publicado: (2021)

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation
por: Yuan, Lunzhi, et al.
Publicado: (2019)

Mesenchymal Bone Marrow-derived Stem Cells Transplantation in Patients with HCV Related Liver Cirrhosis
por: Lukashyk, Sviatlana P., et al.
Publicado: (2014)

The predictive value of blood neutrophil-lymphocyte ratio in patients with end-stage liver cirrhosis following ABO-incompatible liver transplantation
por: Lin, Bingyi, et al.
Publicado: (2016)

Autologous Bone Marrow Stem Cell Transplantation in Liver Cirrhosis after Correcting Nutritional Anomalies, A Controlled Clinical Study
por: Esmaeilzadeh, Abbas, et al.
Publicado: (2019)

Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control
por: Gao, Yun, et al.
Publicado: (2022)

Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
por: Li, Zepeng, et al.
Publicado: (2023)

Effects of bone marrow-derived mesenchymal stem cells transplanted via the portal vein or tail vein on liver injury in rats with liver cirrhosis
por: SONG, YING-MING, et al.
Publicado: (2015)

Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
por: Kim, Ae Jin, et al.
Publicado: (2016)

Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine
por: Hüsing, Anna, et al.
Publicado: (2015)

Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis
por: Zhou, Yang, et al.
Publicado: (2019)

Effect of Autologous Bone Marrow Stem Cell Therapy in Patients with Liver Cirrhosis: A Meta-analysis
por: Wu, Chuan-Xin, et al.
Publicado: (2019)

Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity
por: Maretti-Mira, Ana C., et al.
Publicado: (2023)

Liver Regeneration and Cell Transplantation for End-Stage Liver Disease
por: Li, Yan, et al.
Publicado: (2021)

Transplanted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Mouse
por: Zhang, DingGuo, et al.
Publicado: (2011)

The End-Organ Impairment in Liver Cirrhosis: Appointments for Critical Care
por: Figueiredo, Antonio, et al.
Publicado: (2012)

Mesenchymal stem cell therapy for advanced liver cirrhosis: A case report
por: Rajaram, Ruveena, et al.
Publicado: (2017)

Autologous bone marrow cell transplantation in the treatment of HIV patients with compensated cirrhosis
por: Liu, Baochi, et al.
Publicado: (2020)

Feasibility and safety of intrathecal transplantation of autologous bone marrow mesenchymal stem cells in horses
por: Maia, Leandro, et al.
Publicado: (2015)

Transplantation of autologous bone marrow-derived mesenchymal stem cells for traumatic brain injury☆
por: Jiang, Jindou, et al.
Publicado: (2012)

Intrathecal Transplantation of Autologous and Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Dogs
por: Benavides, Felipe Pérez, et al.
Publicado: (2021)

Hepatocyte and mesenchymal stem cell co-transplantation in rats with acute liver failure
por: Ho, Cheng-Maw, et al.
Publicado: (2020)

High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
por: Sakpal, Sujit Vijay, et al.
Publicado: (2019)

The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites
por: Kim, Jun Jae, et al.
Publicado: (2014)

Fecal Microbiota Transplantation in Liver Cirrhosis
por: Boicean, Adrian, et al.
Publicado: (2023)

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis
por: Mu, Li-ya, et al.
Publicado: (2021)

Long-term outcomes of autologous skeletal myoblast cell-sheet transplantation for end-stage ischemic cardiomyopathy
por: Kainuma, Satoshi, et al.
Publicado: (2021)

Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis
por: Su, Dong-Na, et al.
Publicado: (2020)

Autologous Bone Marrow Mesenchymal Stem Cells Associated with Tantalum Rod Implantation and Vascularized Iliac Grafting for the Treatment of End-Stage Osteonecrosis of the Femoral Head
por: Zhao, Dewei, et al.
Publicado: (2015)

Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis
por: Lu, Wenming, et al.
Publicado: (2023)

Autologous Mesenchymal Stem Cells in Chronic Stroke
por: Bhasin, Ashu, et al.
Publicado: (2011)

Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
por: Tao, Ya-Chao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a1gf29e673hka6i3lmukjkgn3t